Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 713 transactions and raising C$86.1 billion on behalf of our clients in fiscal 20211.2.

Filter our transactions* using the categories below:

Arcellx, Inc.
US$112m
June 2022

Arcellx, Inc.

Joint Bookrunner (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Duke Royalty
£20m
May 2022

Duke Royalty

Joint Bookrunner and Joint Broker (Fundraise)
FINANCIALS CORPORATE BROKING EQUITY CAPITAL MARKETS UK
View transaction detail
Fission Uranium Corp.
C$50m
April 2022

Fission Uranium Corp.

Sole Lead Agent
METALS AND MINING EQUITY CAPITAL MARKETS CANADA
View transaction detail
Selecta Biosciences
US$38.7m
April 2022

Selecta Biosciences

Co-Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Elevation Gold
C$23m
April 2022

Elevation Gold

Sole Bookrunner (Follow-on Offering)
METALS AND MINING EQUITY CAPITAL MARKETS CANADA
Bannerman Energy
A$40m
March 2022

Bannerman Energy

Joint Bookrunner (Follow-On Offering)
METALS AND MINING EQUITY CAPITAL MARKETS AUSTRALIA
Piedmont Lithium
US$131m
March 2022

Piedmont Lithium

Co-Manager (Follow-on Offering)
ENERGY EQUITY CAPITAL MARKETS US
Boss Energy
A$120m
March 2022

Boss Energy

Joint Bookrunner (Follow-On Offering)
METALS AND MINING EQUITY CAPITAL MARKETS AUSTRALIA
The Planting Hope Company Inc.
C$8.0m
March 2022

The Planting Hope Company Inc.

Lead Underwriter
CONSUMER AND RETAIL EQUITY CAPITAL MARKETS CANADA
View transaction detail
Westgold Resources Limited
A$100m
March 2022

Westgold Resources Limited

Sole Bookrunner (Follow-On Offering)
METALS AND MINING EQUITY CAPITAL MARKETS AUSTRALIA
Inari Medical
US$186m
March 2022

Inari Medical

Co-Manager (Follow-on Offering)
HEALTHCARE EQUITY CAPITAL MARKETS US
Aytu Biopharma
US$7.5m
March 2022

Aytu Biopharma

Sole Bookrunner (Follow-on Offering)
HEALTHCARE EQUITY CAPITAL MARKETS US
  1. Company information as of March 31, 2022
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.